Lawsuits allege that some doctors encouraged off-label use of these medications for weight loss patients without providing adequate warnings about possible side effects like delayed gastric emptying, severe gastroparesis, and sudden vision loss
It is a GLP-1 receptor agonist, which basically means it mimics a hormone your body already produces to regulate appetite and fullness
The arrival of GLP-1 drugs is not a panacea for obesity
Int J Mol Sci (2022) 23:1172
Al desarrollar nuevas lneas de productos, las empresas del sector salud enfrentan el desafo de seleccionar ingredientes respaldados por la ciencia, que ofrezcan resultados tangibles y que mantengan una alta estabilidad en sus procesos de manufactura
That is a rare combination, and it is why rheumatologists are paying attention even though no randomized controlled trials specifically evaluating tirzepatide for autoimmune conditions exist yet